Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioAtla (BCAB) Shares Issued (2020 - 2025)

BioAtla's Shares Issued history spans 6 years, with the latest figure at -$47000.0 for Q4 2025.

  • For Q4 2025, Shares Issued fell 147.96% year-over-year to -$47000.0; the TTM value through Dec 2025 reached $51000.0, down 80.46%, while the annual FY2024 figure was $342000.0, 1.79% up from the prior year.
  • Shares Issued reached -$47000.0 in Q4 2025 per BCAB's latest filing, down from $98000.0 in the prior quarter.
  • In the past five years, Shares Issued ranged from a high of $70.8 million in Q4 2021 to a low of -$1.9 million in Q1 2021.
  • Average Shares Issued over 5 years is $8.9 million, with a median of $123500.0 recorded in 2023.
  • Peak YoY movement for Shares Issued: plummeted 34.23% in 2024, then plummeted 147.96% in 2025.
  • A 5-year view of Shares Issued shows it stood at $70.8 million in 2021, then tumbled by 99.62% to $270000.0 in 2022, then tumbled by 44.81% to $149000.0 in 2023, then crashed by 34.23% to $98000.0 in 2024, then tumbled by 147.96% to -$47000.0 in 2025.
  • Per Business Quant, the three most recent readings for BCAB's Shares Issued are -$47000.0 (Q4 2025), $98000.0 (Q4 2024), and $149000.0 (Q4 2023).